Stock Rating Downgrade
The Value Trend Rating for Medifast Inc. (NYSE: MED) fell significantly in recent days from C to F reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our next report.
Recent Price Action
Medifast Inc. (NYSE: MED) stock closed at $66.66 on 12/22/23 after a decline of -2.2%. However, below average trading volume at 67% of normal accompanied the decline. The stock has declined -5.2% during the last week and has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
MED’s future returns on capital are forecasted to be above the cost of capital. Accordingly, the company is expected to continue to be a major Value Builder.
Medifast has a current Value Trend Rating of F (Lowest Rating). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. Medifast has a neutral Appreciation Score of 41 but a poor Power Rating of 21, with the Lowest Value Trend Rating the result.
Be the first to comment